医学
慢性阻塞性肺病
疾病
重症监护医学
人口
肺活量测定
公共卫生
环境卫生
内科学
病理
哮喘
作者
Daiana Stolz,Takudzwa Mkorombindo,Desirée Schumann,Alvar G.N. Agustí,Samuel Y. Ash,Mona Bafadhel,Chunxue Bai,James Duncan Chalmers,Gerard J. Criner,Shyamali C. Dharmage,Frits M.E. Franssen,Urs Frey,MeiLan King Han,Nadia N. Hansel,Nathaniel Mark Hawkins,Ravi Kalhan,Mélanie Königshoff,Fanny W.S. Ko,Trisha M. Parekh,Pippa Powell
出处
期刊:The Lancet
[Elsevier BV]
日期:2022-09-01
卷期号:400 (10356): 921-972
被引量:820
标识
DOI:10.1016/s0140-6736(22)01273-9
摘要
Despite substantial progress in reducing the global impact of many non-communicable diseases, including heart disease and cancer, morbidity and mortality due to chronic respiratory disease continues to increase. This increase is driven primarily by the growing burden of chronic obstructive pulmonary disease (COPD), and has occurred despite the identification of cigarette smoking as the major risk factor for the disease more than 50 years ago. Many factors have contributed to what must now be considered a public health emergency: failure to limit the sale and consumption of tobacco products, unchecked exposure to environmental pollutants across the life course, and the ageing of the global population (partly as a result of improved outcomes for other conditions).
科研通智能强力驱动
Strongly Powered by AbleSci AI